Leveraging TabTransformer Deep Learning on Conventional MRI Radiomics for Accessible and Interpretable Diagnosis of Autism Spectrum Disorder

利用TabTransformer深度学习对常规MRI放射组学进行分析,以实现自闭症谱系障碍的可访问和可解释诊断

阅读:3

Abstract

PURPOSE: This study aims to assess the diagnostic efficacy of a multi-region radiomics analysis utilizing conventional MRI sequences (T1-weighted imaging [T1WI] and T2-weighted imaging [T2WI]) for autism spectrum disorder (ASD), and to investigate the correlations between radiomics features and the severity of clinical symptoms, thereby exploring potential imaging biomarkers. METHODS: This retrospective study included 207 pediatric participants (91 ASD, 116 typically developing controls). Radiomics features were extracted from manually segmented bilateral hippocampus, thalamus, caudate nucleus, and lenticular nucleus on T1WI and T2WI images. Three distinct classifiers (T1WI-only, T2WI-only, T1WI+T2WI combined) were developed using logistic regression (LR), support vector machine (SVM), and a TabTransformer deep learning (DL) model. Diagnostic performance was evaluated via five-fold cross-validation. RESULTS: The TabTransformer DL model utilizing combined T1WI+T2WI features demonstrated superior performance, achieving an area under the curve of 0.900, accuracy of 0.834, sensitivity of 0.843, and specificity of 0.823. Specific radiomic features, predominantly from the left lentiform nucleus and bilateral caudate nucleus, were significantly correlated with clinical severity scores (ABC, CARS). CONCLUSION: Radiomics models leveraging routine MRI sequences demonstrate robust diagnostic utility for ASD. The identified subcortical features, correlating with core symptoms, may serve as viable imaging biomarkers. Future work requires external validation, exploration of automated segmentation, and investigation in larger, multi-center cohorts..

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。